𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant

✍ Scribed by Aimee E. Truesdale; Stephen H. Caldwell; Neeral L. Shah; Curtis K. Argo; Abdullah M. S. Al-Osaimi; Timothy M. Schmitt; Patrick G. Northup


Book ID
110917628
Publisher
Springer
Year
2011
Tongue
English
Weight
169 KB
Volume
24
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sirolimus-based immunosuppression is ass
✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of